Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 701.00
+16.00 (2.34%)
Aug 5, 2026, 2:05 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 58.31 billion as of August 5, 2026. Its market cap has increased by 353.29% in one year.
Market Cap
58.31B
Enterprise Value
56.44B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
701.00
ChartMarket Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 58.31B, an increase of 1,899.60%. That is a compound annual growth rate of 46.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 58.31B | 77.55% |
| Dec 31, 2025 | 32.84B | 203.76% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 168.09B |
| Pell Bio-Med Technology | 56.63B |
| CHO Pharma | 24.72B |
| Oneness Biotech | 22.75B |
| Sunmax Biotechnology | 20.75B |
| TaiMed Biologics | 15.74B |
| Medigen Vaccine Biologics | 15.58B |
| Ever Supreme Bio Technology | 15.11B |